Histone deacetylases (HDACs) are a family of 18 enzymes divided into four classes that remove acetyl groups from lysine residues on histone proteins and non-histone substrates, compacting chromatin and silencing gene transcription. Class I HDACs (1, 2, 3, 8) are nuclear and constitutively expressed, while class II HDACs (4, 5, 6, 7, 9, 10) shuttle between nucleus and cytoplasm in tissue-specific patterns. Class III HDACs are the sirtuins (NAD+-dependent), and class IV contains only HDAC11.
Think of HDACs as the "lock the filing cabinets" crew in a molecular library. Your DNA is wrapped around histone proteins like thread around spools, forming these spools of genetic information. When acetyl groups attach to histones (via HATs — histone acetyltransferases), it's like putting little spacers on the spools — the DNA becomes loose, accessible, and genes can be read. HDACs are the enzymes that pull these spacers off, allowing the DNA to wrap tightly again, locking the genetic information away. In metabolic terms, when you're fasting and producing β-hydroxybutyrate (βOHB), it's like flooding the library with a chemical that handcuffs the locking crew (HDAC inhibition). The filing cabinets stay open, particularly the ones containing anti-inflammatory and antioxidant emergency protocols (FOXO3a, SOD2, MT2). This is why ketogenic diet and Intermittent fasting don't just change your fuel — they directly rewire which genes your cells can access, particularly stress-response and longevity genes.
- Nuclear localization, ubiquitous expression
- HDAC1/2 form complexes with Sin3, NuRD, CoREST → recruited to gene promoters → deacetylate histone H3 and H4 lysine residues → chromatin condensation → transcriptional repression
- HDAC3 forms SMRT/NCoR complex → particularly important for inflammation and metabolism gene regulation
- Mechanism: zinc-dependent catalytic domain cleaves acetyl-lysine bond → releases acetate + lysine with restored positive charge → DNA-histone electrostatic binding strengthens → closed chromatin
βOHB (2-4 mM during fasting, up to 6-8 mM on ketogenic diet) → binds active site of class I HDACs → competitive inhibition with IC50 values:
- HDAC1: 2.4 mM
- HDAC2: 5.3 mM
- HDAC3: 3.1 mM
- HDAC8: 4.7 mM
βOHB inhibition → increased histone H3 lysine 9 (H3K9) and H3K14 acetylation → open chromatin at FOXO3a, MT2, SOD2 promoters → upregulation of:
graph TD
A[Fasting/Ketogenic Diet] --> B[Hepatic Ketogenesis]
B --> C["β-Hydroxybutyrate 2-8 mM"]
C --> D[Binds Class I HDAC Active Site]
D --> E[HDAC Inhibition IC50 2.4-5.3 mM]
E --> F[Increased Histone Acetylation]
F --> G[Open Chromatin at Stress Gene Promoters]
G --> H1[FOXO3a Upregulation]
G --> H2[MT2 Upregulation]
G --> H3[SOD2 Upregulation]
H1 --> I[Antioxidant Defense]
H2 --> I
H3 --> I
I --> J[Reduced Oxidative Stress]
I --> K[Anti-inflammatory State]
Butyrate (gut-derived short-chain fatty acids) → structurally similar to βOHB → inhibits class I HDACs at 0.5-5 mM concentrations (colonic concentrations 10-20 mM) → regulates intestinal immune homeostasis → promotes Treg differentiation via FOXP3 acetylation → anti-inflammatory colonic environment
HDACs also deacetylate:
- p53 → reduces transcriptional activity
- NF-κB → modulates inflammation
- α-tubulin (HDAC6) → regulates microtubule stability, autophagy
- FOXO transcription factors → affects metabolism and longevity pathways
SIRT3 → mitochondrial deacetylase → NAD+-dependent → distinct mechanism from βOHB-inhibited class I HDACs → activated during fasting via increased NAD+/NADH ratio → deacetylates mitochondrial enzymes (SOD2, IDH2, LCAD) → enhances mitochondrial function and antioxidant capacity
¶ Therapeutic Fasting and Ketosis
βOHB-mediated HDAC inhibition provides a molecular mechanism linking metabolic state to epigenetics, explaining why Intermittent fasting and ketogenic diet reduce inflammation independent of weight loss. At βOHB concentrations of 2-4 mM (achievable with 16-18h fasting or 3-4 days ketogenic diet), class I HDAC inhibition becomes therapeutically significant.
- Metamodel 1 (Selfish Systems): HDAC activity reflects energetic state — fed state promotes HDAC activity (gene silencing, anabolic focus), fasted state inhibits HDACs (stress resistance genes activated) — demonstrates Selfish Brain prioritizing survival over growth
- Metamodel 3 (Evolutionary Mismatch): Constant feeding without fasting periods prevents βOHB production → chronic HDAC activity → persistent silencing of stress-response genes → vulnerability to Mismatch Disease
- metabolic flexibility: HDAC modulation by ketones reflects capacity to switch metabolic states and activate appropriate gene programs
- Fasting protocols: Minimum 16h fasting to achieve βOHB 1-2 mM (mild HDAC inhibition); 24-48h for 3-5 mM (robust HDAC inhibition)
- ketogenic diet: Can achieve sustained βOHB 2-6 mM with <20-50g carbohydrate/day
- Butyrate supplementation: 600-1200 mg/day sodium or calcium butyrate provides gut-specific HDAC inhibition (limited systemic bioavailability)
- Resistant starch: 15-30g/day → increases colonic butyrate production → local HDAC inhibition → improved intestinal barrier function
- curcumin and sulforaphane: Natural HDAC inhibitors (micromolar potency) — combinable with fasting for enhanced epigenetic effects
- βOHB >0.5 mM: nutritional ketosis begins
- βOHB 1-3 mM: optimal therapeutic ketosis for HDAC inhibition
- βOHB >5 mM: deep ketosis (prolonged fasting, strict ketogenic diet)
- Butyrate colonic concentration: 10-20 mM (physiological)
- Butyrate systemic concentration: 1-10 μM (after first-pass hepatic metabolism)
- 18 HDAC isoforms in humans across 4 classes (I, II, III, IV)
- Class I HDACs (1, 2, 3, 8) are nuclear, zinc-dependent, ubiquitously expressed
- Class II HDACs (4, 5, 6, 7, 9, 10) shuttle nucleus-cytoplasm, tissue-specific
- Class III HDACs are sirtuins (NAD+-dependent, distinct from classes I/II/IV)
- βOHB inhibits class I HDACs with IC50 2.4-5.3 mM (achievable during fasting/ketosis)
- Butyrate inhibits HDACs at 0.5-5 mM (produced by gut microbiome fermentation)
- HDAC inhibition increases global histone acetylation particularly at H3K9, H3K14 residues
- βOHB-mediated HDAC inhibition upregulates FOXO3a, MT2, SOD2 antioxidant genes
- ketogenic diet increases H3 acetylation in hippocampus and cortex within 7-14 days
- HDAC3 knockout protects against diet-induced obesity and insulin resistance
- Pharmaceutical HDAC inhibitors (vorinostat, romidepsin) approved for cancer treatment
- HDAC6 (cytoplasmic) regulates α-tubulin acetylation and autophagy
- HDAC activity increases with aging (epigenetic drift) → may contribute to inflammaging
- Circadian rhythm regulates HDAC activity (HDAC3 peaks during active phase)
- β-hydroxybutyrate — endogenous class I HDAC inhibitor at IC50 2.4-5.3 mM, linking metabolic state to epigenetic regulation
- ketogenic diet — elevates βOHB to 2-8 mM, providing sustained HDAC inhibition and global histone hyperacetylation
- Intermittent fasting — induces ketogenesis and βOHB production, enabling episodic HDAC inhibition and stress-response gene activation
- Butyrate — gut-derived SCFA that inhibits HDACs similarly to βOHB, regulating intestinal immune homeostasis
- short-chain fatty acids — includes butyrate, propionate, acetate from microbiome fermentation, all possess HDAC inhibitory activity
- sirtuins — class III HDACs requiring NAD+ as cofactor, upregulated during fasting via altered NAD+/NADH ratio
- SIRT3 — mitochondrial sirtuin that deacetylates and activates antioxidant enzymes, distinct from βOHB-inhibited nuclear HDACs
- epigenetics — HDACs are key enzymes catalyzing histone deacetylation, a reversible epigenetic modification regulating transcription
- Histone Methylation — works in concert with acetylation to determine chromatin accessibility and gene expression patterns
- DNA Methylation — often coordinated with HDAC recruitment to silence genes via chromatin remodeling complexes
- chromatin — HDAC activity determines chromatin compaction state (heterochromatin vs euchromatin) and gene accessibility
- gene expression — HDACs repress transcription by condensing chromatin and preventing transcription factor binding
- FOXO3a — longevity transcription factor upregulated by HDAC inhibition, drives antioxidant and stress-resistance gene programs
- antioxidant — HDAC inhibition enhances expression of SOD2, catalase, glutathione peroxidase via FOXO activation
- inflammation — HDAC inhibition reduces NF-κB activity and pro-inflammatory cytokine production
- NLRP3 inflammasome — suppressed by βOHB both directly (GPR109A signaling) and indirectly (HDAC inhibition reducing priming)
- NAFLD — βOHB-mediated HDAC3 inhibition reduces hepatic lipogenesis and steatosis progression
- neurodegeneration — HDAC inhibitors increase BDNF, enhance autophagy, reduce neuroinflammation in Alzheimer's and Parkinson's models
- Cancer — HDAC inhibitors induce cancer cell differentiation, apoptosis, and cell cycle arrest; vorinostat approved for cutaneous T-cell lymphoma
- autophagy — enhanced by HDAC inhibition through increased LC3 and BNIP3 expression; HDAC6 directly regulates autophagosome-lysosome fusion
- metabolic flexibility — capacity to produce ketones and inhibit HDACs reflects metabolic adaptability and stress resilience
- Mitochondrial Information Processing System — ketone bodies like βOHB serve as metabolic signals that regulate nuclear gene expression via HDAC modulation
- gut microbiome — produces butyrate and other SCFA HDAC inhibitors, linking diet and microbial metabolism to host epigenetics
- GPR109A — βOHB receptor that mediates anti-inflammatory effects independent of HDAC inhibition
- hepatic ketogenesis — produces βOHB in liver mitochondria via HMGCS2, providing systemic HDAC inhibition during fasting
- curcumin — polyphenol HDAC inhibitor from turmeric, demonstrates epigenetic anticancer effects in vitro
- sulforaphane — cruciferous vegetable compound that inhibits HDACs and DNMTs, dual epigenetic modulator
- PPARα — activated during fasting, drives ketogenesis and βOHB production, indirectly modulating HDAC activity
- mTORC1 — inhibited by fasting, coordinates with HDAC modulation to shift from growth to stress-resistance programs
- NF-κB — acetylation status regulated by HDACs affects transcriptional activity and inflammatory signaling